Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Burden of fungal asthma in Africa: A systematic review and meta-analysis.

Kwizera R, Musaazi J, Meya DB, Worodria W, Bwanga F, Kajumbula H, Fowler SJ, Kirenga BJ, Gore R, Denning DW.

PLoS One. 2019 May 16;14(5):e0216568. doi: 10.1371/journal.pone.0216568. eCollection 2019.

2.

Comparison of GeneXpert cycle threshold values with smear microscopy and culture as a measure of mycobacterial burden in five regional referral hospitals of Uganda- A cross-sectional study.

Najjingo I, Muttamba W, Kirenga BJ, Nalunjogi J, Bakesiima R, Olweny F, Lusiba P, Katamba A, Joloba M, Ssengooba W.

PLoS One. 2019 May 15;14(5):e0216901. doi: 10.1371/journal.pone.0216901. eCollection 2019.

3.

The health and social implications of household air pollution and respiratory diseases.

Simkovich SM, Goodman D, Roa C, Crocker ME, Gianella GE, Kirenga BJ, Wise RA, Checkley W.

NPJ Prim Care Respir Med. 2019 Apr 26;29(1):12. doi: 10.1038/s41533-019-0126-x. Review.

4.

Prevalence and factors associated with asthma among adolescents and adults in Uganda: a general population based survey.

Kirenga BJ, de Jong C, Katagira W, Kasozi S, Mugenyi L, Boezen M, van der Molen T, Kamya MR.

BMC Public Health. 2019 Feb 22;19(1):227. doi: 10.1186/s12889-019-6562-2.

5.

Urban-Rural Disparities in Chronic Obstructive Pulmonary Disease Management and Access in Uganda.

Robertson NM, Nagourney EM, Pollard SL, Siddharthan T, Kalyesubula R, Surkan PJ, Hurst JR, Checkley W, Kirenga BJ.

Chronic Obstr Pulm Dis. 2019 Jan 4;6(1):17-28. doi: 10.15326/jcopdf.6.1.2018.0143.

6.

Lung Function of Children at Three Sites of Varying Ambient Air Pollution Levels in Uganda: A Cross Sectional Comparative Study.

Kirenga BJ, Nantanda R, de Jong C, Mugenyi L, Meng Q, Aniku G, Williams S, Aanyu-Tukamuhebwa H, Kamya M, Schwander S, van der Molen T, Mohsenin V.

Int J Environ Res Public Health. 2018 Nov 26;15(12). pii: E2653. doi: 10.3390/ijerph15122653.

7.

The impact of HIV on the prevalence of asthma in Uganda: a general population survey.

Kirenga BJ, Mugenyi L, de Jong C, Lucian Davis J, Katagira W, van der Molen T, Kamya MR, Boezen M.

Respir Res. 2018 Sep 21;19(1):184. doi: 10.1186/s12931-018-0898-5.

8.

International research and guidelines on post-tuberculosis chronic lung disorders: a systematic scoping review.

van Kampen SC, Wanner A, Edwards M, Harries AD, Kirenga BJ, Chakaya J, Jones R.

BMJ Glob Health. 2018 Jul 23;3(4):e000745. doi: 10.1136/bmjgh-2018-000745. eCollection 2018.

9.

Electric scooters: batteries in the battle against ambient air pollution?

van Boven JFM, An PL, Kirenga BJ, Chavannes NH.

Lancet Planet Health. 2017 Aug;1(5):e168-e169. doi: 10.1016/S2542-5196(17)30079-7. Epub 2017 Aug 4. No abstract available.

10.

Rates of asthma exacerbations and mortality and associated factors in Uganda: a 2-year prospective cohort study.

Kirenga BJ, de Jong C, Mugenyi L, Katagira W, Muhofa A, Kamya MR, Boezen HM, van der Molen T.

Thorax. 2018 Oct;73(10):983-985. doi: 10.1136/thoraxjnl-2017-211157. Epub 2018 May 11.

PMID:
29752346
11.

The complications of treating chronic obstructive pulmonary disease in low income countries of sub-Saharan Africa.

van Gemert FA, Kirenga BJ, Gebremariam TH, Nyale G, de Jong C, van der Molen T.

Expert Rev Respir Med. 2018 Mar;12(3):227-237. doi: 10.1080/17476348.2018.1423964. Epub 2018 Jan 10. Review.

PMID:
29298106
12.

A pre-post intervention study of pulmonary rehabilitation for adults with post-tuberculosis lung disease in Uganda.

Jones R, Kirenga BJ, Katagira W, Singh SJ, Pooler J, Okwera A, Kasiita R, Enki DG, Creanor S, Barton A.

Int J Chron Obstruct Pulmon Dis. 2017 Dec 11;12:3533-3539. doi: 10.2147/COPD.S146659. eCollection 2017.

13.

Erratum: Treating tobacco dependence: guidance for primary care on life-saving interventions. Position statement of the IPCRG.

Schayck OCPV, Williams S, Barchilon V, Baxter N, Jawad M, Katsaounou PA, Kirenga BJ, Panaitescu C, Tsiligianni IG, Zwar N, Ostrem A.

NPJ Prim Care Respir Med. 2017 Sep 5;27(1):52. doi: 10.1038/s41533-017-0048-4.

14.

Treating tobacco dependence: guidance for primary care on life-saving interventions. Position statement of the IPCRG.

Van Schayck OCP, Williams S, Barchilon V, Baxter N, Jawad M, Katsaounou PA, Kirenga BJ, Panaitescu C, Tsiligianni IG, Zwar N, Ostrem A.

NPJ Prim Care Respir Med. 2017 Jun 9;27(1):38. doi: 10.1038/s41533-017-0039-5. Review. Erratum in: NPJ Prim Care Respir Med. 2017 Sep 5;27(1):52.

15.

Incomplete sputum smear microscopy monitoring among smear-positive tuberculosis patients in Uganda.

Nakaggwa P, Odeke R, Kirenga BJ, Bloss E.

Int J Tuberc Lung Dis. 2016 May;20(5):594-9. doi: 10.5588/ijtld.15.0591.

PMID:
27084811
16.

Rapid assessment of the demand and supply of tobacco dependence pharmacotherapy in Uganda.

Kirenga BJ, Jones R, Muhofa A, Nyakoojo G, Williams S.

Public Health Action. 2016 Mar 21;6(1):35-7. doi: 10.5588/pha.15.0070. Epub 2016 Feb 17.

17.

Guidance on the diagnosis and management of asthma among adults in resource limited settings.

Kirenga BJ, Schwartz JI, de Jong C, van der Molen T, Okot-Nwang M.

Afr Health Sci. 2015 Dec;15(4):1189-99. doi: 10.4314/ahs.v15i4.18.

18.

Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.

Nakiyingi L, Nonyane BA, Ssengooba W, Kirenga BJ, Nakanjako D, Lubega G, Byakika-Kibwika P, Joloba ML, Ellner JJ, Dorman SE, Mayanja-Kizza H, Manabe YC.

PLoS One. 2015 Jul 29;10(7):e0133756. doi: 10.1371/journal.pone.0133756. eCollection 2015.

19.

The State of Ambient Air Quality in Two Ugandan Cities: A Pilot Cross-Sectional Spatial Assessment.

Kirenga BJ, Meng Q, van Gemert F, Aanyu-Tukamuhebwa H, Chavannes N, Katamba A, Obai G, van der Molen T, Schwander S, Mohsenin V.

Int J Environ Res Public Health. 2015 Jul 15;12(7):8075-91. doi: 10.3390/ijerph120708075.

20.

COPD: early diagnosis and treatment to slow disease progression.

van der Molen T, Kirenga BJ.

Int J Clin Pract. 2015 May;69(5):513-4. doi: 10.1111/ijcp.12622. No abstract available.

PMID:
25913913
21.

Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.

Nakiyingi L, Ssengooba W, Nakanjako D, Armstrong D, Holshouser M, Kirenga BJ, Shah M, Mayanja-Kizza H, Joloba ML, Ellner JJ, Dorman SE, Manabe YC.

BMC Infect Dis. 2015 Feb 15;15:62. doi: 10.1186/s12879-015-0812-4.

22.

Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control.

Kirenga BJ, Ssengooba W, Muwonge C, Nakiyingi L, Kyaligonza S, Kasozi S, Mugabe F, Boeree M, Joloba M, Okwera A.

BMC Public Health. 2015 Jan 21;15:13. doi: 10.1186/s12889-015-1376-3.

23.

TB-HAART trial--authors' reply.

Mfinanga SG, Kirenga BJ, Chanda DM, Connolly C, Mwaba P, Joloba M, Zumla A; TB-HAART Study Group.

Lancet Infect Dis. 2015 Jan;15(1):15-6. doi: 10.1016/S1473-3099(14)71051-5. No abstract available.

PMID:
25541163
24.

Risk factors for asthma exacerbation in patients presenting to an emergency unit of a national referral hospital in Kampala, Uganda.

Sanya RE, Kirenga BJ, Worodria W, Okot-Nwang M.

Afr Health Sci. 2014 Sep;14(3):707-15. doi: 10.4314/ahs.v14i3.29.

25.

Evaluation of Cepheid's Xpert MTB/Rif test on pleural fluid in the diagnosis of pleural tuberculosis in a high prevalence HIV/TB setting.

Lusiba JK, Nakiyingi L, Kirenga BJ, Kiragga A, Lukande R, Nsereko M, Ssengooba W, Katamba A, Worodria W, Joloba ML, Mayanja-Kizza H.

PLoS One. 2014 Jul 22;9(7):e102702. doi: 10.1371/journal.pone.0102702. eCollection 2014.

26.

Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial.

Mfinanga SG, Kirenga BJ, Chanda DM, Mutayoba B, Mthiyane T, Yimer G, Ezechi O, Connolly C, Kapotwe V, Muwonge C, Massaga J, Sinkala E, Kohi W, Lyantumba L, Nyakoojo G, Luwaga H, Doulla B, Mzyece J, Kapata N, Vahedi M, Mwaba P, Egwaga S, Adatu F, Pym A, Joloba M, Rustomjee R, Zumla A, Onyebujoh P.

Lancet Infect Dis. 2014 Jul;14(7):563-71. doi: 10.1016/S1473-3099(14)70733-9. Epub 2014 May 5. Erratum in: Lancet Infect Dis. 2014 Jul;14(7):548.

PMID:
24810491
27.

Evaluation of asthma control using Global Initiative for Asthma criteria and the Asthma Control Test in Uganda.

Serugendo AN, Kirenga BJ, Hawkes M, Nakiyingi L, Worodria W, Okot-Nwang M.

Int J Tuberc Lung Dis. 2014 Mar;18(3):371-6. doi: 10.5588/ijtld.13.0699.

PMID:
24670578
28.

Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study.

Kirenga BJ, Levin J, Ayakaka I, Worodria W, Reilly N, Mumbowa F, Nabanjja H, Nyakoojo G, Fennelly K, Nakubulwa S, Joloba M, Okwera A, Eisenach KD, McNerney R, Elliott AM, Mugerwa RD, Smith PG, Ellner JJ, Jones-López EC.

PLoS One. 2014 Mar 7;9(3):e90614. doi: 10.1371/journal.pone.0090614. eCollection 2014.

29.

Chest X-ray vs. Xpert® MTB/RIF assay for the diagnosis of sputum smear-negative tuberculosis in Uganda.

Wekesa C, Kirenga BJ, Joloba ML, Bwanga F, Katamba A, Kamya MR.

Int J Tuberc Lung Dis. 2014 Feb;18(2):216-9. doi: 10.5588/ijtld.13.0464.

PMID:
24429316
30.

A woman with breathlessness: a practical approach to diagnosis and management.

Kaplan A, Gruffydd-Jones K, van Gemert F, Kirenga BJ, Medford AR.

Prim Care Respir J. 2013 Dec;22(4):468-76. doi: 10.4104/pcrj.2013.00100.

31.

Tuberculin skin test conversion among HIV patients on antiretroviral therapy in Uganda.

Kirenga BJ, Worodria W, Massinga-Loembe M, Nalwoga T, Manabe YC, Kestens L, Colebunders R, Mayanja-Kizza H.

Int J Tuberc Lung Dis. 2013 Mar;17(3):336-41. doi: 10.5588/ijtld.12.0298.

PMID:
23407223
32.

Advances in the Diagnosis, Treatment and Control of HIV Associated Tuberculosis.

Kirenga BJ, Chanda DM, Muwonge CM, Yimer G, Adatu FE, Onyebujoh PC.

Afr J Infect Dis. 2012;6(2):29-40.

Supplemental Content

Loading ...
Support Center